Inverness Medical Innovations Completes $150 Million Public Offering

August 11, 2009

Cahill represented the underwriters including Jefferies & Company, Inc. and Wells Fargo Securities, LLC in connection with Inverness Medical Innovations, Inc.'s public offering of $150,000,000 7.875% Senior Notes due 2016. The net proceeds from the sale of the notes are being used to fund the acquisition of Concateno PLC.